Skip to main content
. 2016 Jul 24;8(36):60487–60495. doi: 10.18632/oncotarget.10814

Table 3. Novel variants in BRCA1/2 with probably deleterious effect from the in silico analysis detected in 940 probands with personal and/or family history of breast/ovary cancer.

ID Exon/ Intron Mutation HGVS cDNA HGVS protein PH (age) FH (1st and/or 2nd degree) Align GVGD PolyPhen SIFT
BRCA1
AB0392 14i Splice defect c.4484+3A>G ª Br (40) Br
AB0081U 7 Missense c.341C>G p.Ser114Cys Br (45) Br; Co Class C0 Possibly damaging Afect protein function
BRCA2
AB0376 14 In Frame del c.7426_7428delGAA p.Glu2476del Br (39) NO
AB0402 10 Missense c.1277A>C p.Lys426Thr Br (42) Br Class C0 Possibly damaging Afect protein function
AB0185 11 Missense c.3316A>G p.Ser1106Gly Healthy (43) Br, Gastric Class C0 Probably damaging Afect protein function
AB0231 14 Missense c.7159G>C p.Ala2387Pro Healthy (46) Br, Ov Class C0 Possibly damaging Afect protein function
AB0258 18 Missense c.8038G>A p.Asp2680Asn Br (37) Br Class C0 Probably damaging Afect protein function
AB0435 27 Missense c.9794G>A p.Cys3265Tyr Br (50 & 52) NO Class C0 Possibly damaging Afect protein function

PH: Personal historyof cancer; FH: Family historyof cancer; Br: Breast; Ov: Ovary; Co: colon.

ª: coexistent with in BRCA2 c.8021delA, p.Lys2674Argfs -also novel-.

Age range at first diagnostic: 37-50 years; mean+SD=42.17+4.71(n=6)